C07C 275/10
Being further substituted by singly-bound oxygen atoms
Official title: being further substituted by singly-bound oxygen atoms
C07C275/10 (Being further substituted by singly-bound oxygen atoms) appears on 75 US grants and 58 published applications in this corpus.
Search patents in C07C- Granted patents
- 75
- Published applications
- 58
- Assignees
- 63
- Inventors
- 259
- Latest grant
- 30 Sep 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 5 | 0 |
| 1977 | 3 | 0 |
| 1978 | 0 | 0 |
| 1979 | 1 | 0 |
| 1980 | 3 | 0 |
| 1981 | 2 | 0 |
| 1982 | 2 | 0 |
| 1983 | 1 | 0 |
| 1984 | 0 | 0 |
| 1985 | 1 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 2 | 0 |
| 1990 | 0 | 0 |
| 1991 | 4 | 0 |
| 1992 | 1 | 0 |
| 1993 | 1 | 0 |
| 1994 | 0 | 0 |
| 1995 | 4 | 0 |
| 1996 | 2 | 0 |
| 1997 | 3 | 0 |
| 1998 | 0 | 0 |
| 1999 | 0 | 0 |
| 2000 | 2 | 0 |
| 2001 | 1 | 0 |
| 2002 | 0 | 0 |
| 2003 | 2 | 2 |
| 2004 | 1 | 7 |
| 2005 | 0 | 4 |
| 2006 | 4 | 3 |
| 2007 | 2 | 2 |
| 2008 | 1 | 1 |
| 2009 | 1 | 1 |
| 2010 | 3 | 2 |
| 2011 | 2 | 2 |
| 2012 | 0 | 1 |
| 2013 | 1 | 2 |
| 2014 | 3 | 1 |
| 2015 | 0 | 0 |
| 2016 | 2 | 6 |
| 2017 | 0 | 4 |
| 2018 | 4 | 0 |
| 2019 | 2 | 2 |
| 2020 | 0 | 0 |
| 2021 | 0 | 7 |
| 2022 | 2 | 2 |
| 2023 | 2 | 1 |
| 2024 | 4 | 4 |
| 2025 | 1 | 0 |
| 2026 | 0 | 4 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- P62 ligand compound, and composition for preventing, ameliorating or treating proteinopathies comprising the same30 Sep 2025US 12,427,346 B2Autotac Inc.
- AUTOTAC chimeric compound, and composition for preventing, ameliorating or treating diseases through targeted protein degradation comprising the same29 Oct 2024US 12,129,218 B2Autotac Inc.
- Myc-Max inhibitor compound therapeutics for cancer treatment, methods and uses associated therewith25 Jun 2024US 12,017,975 B2The University of British Columbia
- P62 ligand compound, and composition for preventing, ameliorating or treating proteinopathies comprising the same14 May 2024US 11,981,618 B2Autotac Inc.
- Composition, production method for composition, and production method for unsaturated compound6 Feb 2024US 11,891,472 B2Resonac Corporation
- Hydrocarbon terminal group-containing compound, surface treatment agent, and article8 Oct 2026US 2026/0308392 A1Shin-Etsu Chemical Co., Ltd.
- Lipid compound and composition for delivery of active substance2 Jul 2026US 2026/0184669 A1Korea Research Institute of Bioscience and Biotechnology
- Urea-based ice recrystallization inhibitor compounds and compositions, and uses thereof for cryopreservation28 May 2026US 2026/0146238 A1PanTHERA CryoSolutions Inc.
- Ionizable lipids and compositions comprising same19 Mar 2026US 2026/0076914 A1Barcode Nanotech Ltd.
- Azido-containing monomers, polymers, and articles22 Aug 2024US 2024/0279161 A13M Innovative Properties Company
Most cited
By later US patents
- High molecular weight polymer-based prodrugs182US 5,614,549 AEnzon, Inc. · 1997
- Photochemical crosslinkers for polymer coatings and substrate tie-layer43US 7,772,393 B2Innovative Surface Technologies, Inc. · 2010
- 11,12-Secoprostaglandins39US 3,989,749 AMerck & Co., Inc. · 1976
- Photochemical crosslinkers for polymer coatings and substrate tie-layer30US 8,487,137 B2Innovative Surface Technologies, Inc. · 2013
- Self- and diol reactive formaldehyde-free crosslinking monomers and their derived polymers17US 4,864,055 AAir Products and Chemicals, Inc. · 1989